Pregabalin and gabapentin use in France from 2012 to 2023, impact of prescription restrictions, a time series analysis [0.03%]
2012至2023年法国普瑞巴林和加巴喷丁的使用情况及处方限制的影响：时间序列分析
Alexandre Michel,Michel Prade,David De Bandt
Alexandre Michel
Introduction: Gabapentinoids use is accompanied by increased misuse, particularly for pregabalin. In May 2021, France introduced secure prescription requirements for pregabalin. This paper aims to analyse variations in ga...
Re: Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States [0.03%]
舌下和缓释丁丙诺啡治疗的留存率及辍治情况：基于美国具有代表性的商业保险参保者的数据比较分析
Angela M DeVeaugh-Geiss,Howard D Chilcoat
Angela M DeVeaugh-Geiss
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparison [0.03%]
在美国农村和城市地区注射毒品者中HIV和/或丙肝病毒传播变化的药物市场及结构性决定因素的影响模型：一项对比研究
Natasha K Martin,Daniela Abramovitz,William H Eger et al.
Natasha K Martin et al.
Background: The impact of changing drug use patterns on hepatitis C virus (HCV) and HIV incidence among people who inject drugs (PWID) in the US is understudied. ...
Exploring models of safer supply provision: A qualitative study on the preferences of people who access the unregulated drug market [0.03%]
探究安全药物供应模型：一项关于接触非法药物市场人群偏好的定性研究
Abby Hutchison,Phoenix Beck McGreevy,Benjamin Enns et al.
Abby Hutchison et al.
Background: People who use drugs and other experts have long advocated for a supply of regulated drugs of known quality and composition as an alternative to the toxic and unregulated drug supply that is causing unpreceden...
Evan Mills
Evan Mills
Policy fragmentation contributes to the myriad environmental impacts of the cannabis industry and impedes solutions. Examination of how this plays out in the context of the US provides real-world examples, further complicated by the lack of...
Peer-delivered mail-order self-collection and linkage to treatment for hepatitis C virus infection among users of a harm reduction service in Denmark [0.03%]
丹麦危害减少服务机构中同伴配送邮寄自取以及与丙型肝炎病毒感染治疗联系的研究
Jonas Demant,Stephen Strunge Nilsson,Louise Krohn-Dehli et al.
Jonas Demant et al.
Background: Hepatitis C virus infection remains a major public health challenge, particularly among people who inject drugs. Despite the availability of highly effective direct-acting antiviral treatment, many remain undi...
"Stigma is our most powerful enemy": Understanding opioid use disorder stigma and the role of peer support in rural Maryland [0.03%]
“污名是我们的最强对手”：理解马里兰州农村地区阿片类药物使用障碍的污名及同伴支持的作用
M S Anvari,C A Sacko,G E Atkinson et al.
M S Anvari et al.
Introduction: Rural areas of the U.S. face persistent challenges with opioid-related fatalities and opioid use disorder (OUD) treatment retention. One significant barrier is stigma surrounding OUD and its treatment. Rural...
Characterizing intersystem and community values to enhance opioid use disorder treatments: Communities That Heal intervention in New York [0.03%]
描述跨系统和社区价值观以增强阿片类药物使用障碍治疗：“纽约社区康复计划”干预措施
Dean Rivera,Anindita Dasgupta,Allyson G Cogan et al.
Dean Rivera et al.
Background: In response to rising overdose deaths, the State of New York established multisystem coalitions in 16 counties to tackle the opioid crisis. These coalitions brought together stakeholders from various systems, ...
Preferences for Pre-exposure Prophylaxis (PrEP) among people who use drugs in Thailand: A discrete choice experiment [0.03%]
泰国药物使用者对暴露前预防(PrEP)的偏好：一种离散选择实验的方法
Ajaree Rayanakorn,Piyameth Dilokthornsakul,Donsuk Pongnikorn et al.
Ajaree Rayanakorn et al.
Background: Pre-exposure prophylaxis (PrEP) is effective in preventing HIV. However, engaging people who use drugs (PWUDs) in PrEP services remains challenging due to societal, legal, and structural barriers. This study e...
Comparing drug policies: An assessment of the validity and reliability of the global drug policy index [0.03%]
药物政策比较：全球药物政策指数的有效性和可靠性的评估
David Bewley-Taylor,Matthew Wall,Jack Tudor et al.
David Bewley-Taylor et al.
Background: The Global Drug Policy Index (GDPI) is an instrument that attempts to comparatively evaluate national drug policies at a global scale. This paper assesses the validity and reliability of this new Index, speaki...